Cystic Fibrosis, Clinical Trials & COVID-19
Dr Damian Downey gives an overview of some recent papers on COVID-19 and cystic fibrosis (CF) and the impact of lockdown on CF. He then continues with what can research sites and clinical trial network do. Additionally, in this presentation, Dr Downey provides updates on the therapeutic development network data on the impact of SARS-CoV-2 on clinical trials, presents a summary of the COVID-19 antibody response in CF (CAR-CF study) and discusses the challenges of the CF clinical research ahead.
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
Dr Damian Downey
Consultant Respiratory Physician